查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1469791

全球藥品測試與分析服務市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Pharmaceutical Testing and Analytical Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

全球藥物測試和分析服務市場需求預計將從 2023 年的 79.8 億美元達到 2032 年近 149.1 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.19%。

藥物測試和分析服務涵蓋一系列用於評估藥物成分和產品的安全性、品質和有效性的實驗室技術和方法。這些服務涉及測試藥物原料、中間體和成品，以確保符合監管標準、藥典要求和品質規範。藥物測試可能包括化學分析、微生物測試、穩定性測試、溶出度測試和生物利用度研究。分析服務提供有關藥物配方的特性、純度、效力和穩定性的關鍵資訊，支持藥物開發、製造和法規核准流程。

市場動態

監管機構對藥品安全性、有效性和品質的日益重視推動了對綜合測試和分析服務的需求。藥品測試和分析服務對於確保遵守監管標準、識別雜質以及驗證藥品的效力、穩定性和純度至關重要。此外，藥物配方（包括生物製劑、生物相似藥和特殊藥物）日益複雜，推動了對先進分析技術和專業測試服務的需求，以遵守監管要求並確保產品品質。此外，在研發投資激增、慢性病流行以及個人化醫療需求不斷成長等因素的推動下，製藥和生物技術行業不斷擴大，正在推動對合約研究組織 (CRO) 和合約外包測試和分析服務的需求。組織(CMO)。此外，藥物測試和分析服務中質譜、色譜、光譜和分子診斷等先進技術的持續採用，提高了分析方法的準確性、靈敏度和通量，從而推動了市場成長。

此外，製藥業外包非核心活動、成本控制策略和營運效率的上升趨勢正在推動對專業供應商外包測試和分析服務的需求。此外，對產品表徵、製程驗證和品質控制不斷擴大的監管要求推動了對提供合規性、方法開發和驗證方面專業知識的專業測試服務的需求。此外，對藥品生產設施中生物安全和污染控制的日益關注正在推動對環境監測、微生物測試和無菌測試服務的需求，從而促進市場成長。然而，日益激烈的競爭和監管要求可能會在未來幾年挑戰藥物測試和分析服務市場的發展。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球藥物測試和分析服務市場的每個細分市場進行包容性評估。藥物測試和分析服務業的成長和趨勢為本研究提供了整體方法。

市場區隔

藥品測試和分析服務市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按服務類型

  • 生物分析測試（基於細胞的測定、病毒學測試等）
  • 方法開發和驗證（可萃取物和浸出物方法開發和驗證、穩定性指示方法驗證、製程雜質方法開發和驗證等）
  • 原料測試（重金屬測試、完整藥典測試等）
  • 穩定性測試（原料藥穩定性測試、製劑評估穩定性測試等）
  • 微生物檢測（微生物限量檢測、無菌檢測、內毒素檢測等）
  • 其他

按最終用戶

  • 醫療器材公司
  • 製藥及生物製藥公司
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的藥物測試和分析服務市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物測試和分析服務市場的主要參與者包括 Eurofins Scientific、Laboratory Corporation of America Holdings、Charles River Laboratories International, Inc.、SGS SA、Intertek Group plc、RD Laboratories, Inc.、無錫藥明康德有限公司、 Dynalabs LLC （Infinity Laboratories）、ARL Bio Pharma。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：藥物測試和分析服務 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按服務類型分類的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球藥物測試和分析服務市場分析：按服務類型

  • 按服務類型概述
  • 歷史和預測數據
  • 按服務類型分析
  • 生物分析測試（細胞分析、病毒學測試等）
  • 方法開發和驗證（可萃取物和浸出物方法開發和驗證、穩定性指示方法驗證、製程雜質方法開發和驗證等）
  • 原料測試（重金屬測試、完整藥典測試等）
  • 穩定性測試（原料藥穩定性測試、製劑評估穩定性測試等）
  • 微生物檢測（微生物限量檢測、無菌檢測、內毒素檢測等）
  • 其他

第 6 章：全球藥物測試和分析服務市場分析：按最終用戶

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫療器材公司
  • 製藥及生物製藥公司
  • 其他

第 7 章：全球藥物測試和分析服務市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：藥物測試與分析服務公司的競爭格局

  • 藥物測試和分析服務市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Eurofins Scientific
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Laboratory Corporation of America Holdings
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Charles River Laboratories International Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • SGS SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Intertek Group plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • RD laboratories Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Wuxi AppTec Co. Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dynalabs LLC (Infinity Laboratories)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ARL Bio Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112114194

The global demand for Pharmaceutical Testing and Analytical Services Market is presumed to reach the market size of nearly USD 14.91 Billion by 2032 from USD 7.98 Billion in 2023 with a CAGR of 7.19% under the study period 2024 - 2032.

Pharmaceutical testing and analytical services encompass a range of laboratory techniques and methods used to assess the safety, quality, and effectiveness of pharmaceutical ingredients & products. These services involve testing pharmaceutical raw materials, intermediates, and finished products to ensure compliance with regulatory standards, pharmacopeial requirements, and quality specifications. Pharmaceutical testing may include chemical analysis, microbiological testing, stability testing, dissolution testing, and bioavailability studies. Analytical services provide critical information on pharmaceutical formulations' identity, purity, potency, and stability, supporting drug development, manufacturing, and regulatory approval processes.

MARKET DYNAMICS

The increasing emphasis by regulatory authorities on drug safety, efficacy, and quality drives the demand for comprehensive testing and analytical services. Pharmaceutical testing and analytical services are crucial in ensuring compliance with regulatory standards, identifying impurities, and validating pharmaceutical products' potency, stability, and purity. Moreover, the growing complexity of drug formulations, including biologics, biosimilars, and specialty drugs, drives the need for advanced analytical techniques and specialized testing services to adhere to regulatory requirements and ensure product quality. Additionally, the expanding pharmaceutical and biotechnology industry, driven by factors such as surging R&D investments, spurring prevalence of chronic diseases, and growing demand for personalized medicine, is fueling the demand for outsourced testing and analytical services from contract research organizations (CROs) and contract manufacturing organizations (CMOs). Furthermore, the spurring adoption of advanced technologies such as mass spectrometry, chromatography, spectroscopy, and molecular diagnostics in pharmaceutical testing and analytical services is enhancing analytical methods' accuracy, sensitivity, and throughput, thereby driving market growth.

Moreover, the rising trend of outsourcing non-core activities, cost containment strategies, and operational efficiencies in the pharmaceutical industry is driving the demand for outsourcing testing and analytical services to specialized providers. Additionally, the expanding regulatory requirements for product characterization, process validation, and quality control drive the demand for specialized testing services that offer expertise in compliance, method development, and validation. Furthermore, the growing focus on biosafety, biosecurity, and contamination control in pharmaceutical manufacturing facilities is driving the demand for environmental monitoring, microbial testing, and sterility testing services, contributing to market growth. However, increasing competition and regulatory requirements may challenge the development of the pharmaceutical testing and analytical services market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical testing and analytical services. The growth and trends of pharmaceutical testing and analytical services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pharmaceutical testing and analytical services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

  • Bioanalytical Testing (Cell-Based Assays, Virology Testing, And Others)
  • Method Development & Validation (Extractables & Leachables Method Development And Validation, Stability-Indicating Method Validation, Process Impurity Method Development & Validation, And Others)
  • Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, And Others)
  • Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, And Others)
  • Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, And Others)
  • Others

By End-User

  • Medical Device Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Testing and Analytical Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmaceutical Testing and Analytical Services market include Eurofins Scientific, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., Dynalabs LLC (Infinity Laboratories), ARL Bio Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service Type
    • 3.7.2 Market Attractiveness Analysis By End-user
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY SERVICE TYPE

  • 5.1 Overview by Service Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Service Type
  • 5.4 Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Historic and Forecast Sales by Regions
  • 5.5 Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Historic and Forecast Sales by Regions
  • 5.6 Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Historic and Forecast Sales by Regions
  • 5.7 Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Historic and Forecast Sales by Regions
  • 5.8 Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Historic and Forecast Sales by Regions
  • 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY END-USER

  • 6.1 Overview by End-user
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-user
  • 6.4 Medical Device Companies Historic and Forecast Sales by Regions
  • 6.5 Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales by Regions
  • 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES COMPANIES

  • 8.1. Pharmaceutical Testing And Analytical Services Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Eurofins Scientific
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Laboratory Corporation of America Holdings
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Charles River Laboratories International Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. SGS S.A.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Intertek Group plc
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. RD laboratories Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Wuxi AppTec Co. Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Dynalabs LLC (Infinity Laboratories)
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. ARL Bio Pharma
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service Type (USD MN)
  • Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Market Sales by Geography (USD MN)
  • Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Market Sales by Geography (USD MN)
  • Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Market Sales by Geography (USD MN)
  • Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Market Sales by Geography (USD MN)
  • Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-user (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Pharmaceutical Testing And Analytical Services Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pharmaceutical Testing And Analytical Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Pharmaceutical Testing And Analytical Services Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service Type
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service Type (USD MN)
  • Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Market Sales by Geography (USD MN)
  • Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Market Sales by Geography (USD MN)
  • Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Market Sales by Geography (USD MN)
  • Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Market Sales by Geography (USD MN)
  • Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.